Siroj Dejhansathit Attaya Suvannasankha
10.1177/2324709619832332
J Investig Med High Impact Case Rep
2019 Jan-Dec;7:2324709619832332.
al amyloidosis blood coagulation disorders factor x deficiency
CC BY
https://pubmed.ncbi.nlm.nih.gov/30947547/
Blood Coagulation Factors / administration & dosage Factor X / administration & dosage Factor X Deficiency / complications Hemorrhage / etiology Immunoglobulin Light-chain Amyloidosis / complications
Blood Coagulation Factors / administration & dosage Factor X / administration & dosage Factor X Deficiency / complications Hemorrhage / etiology Immunoglobulin Light-chain Amyloidosis / complications Case Reports Research Support, U.S. Gov't, Non-P.H.S. Adult Aged Amyloidogenic Proteins / metabolism Antineoplastic Agents / therapeutic use Factor X Deficiency / blood Factor X Deficiency / drug therapy Female Hemorrhage / drug therapy Humans Immunoglobulin Light-chain Amyloidosis / drug therapy Immunosuppressive Agents / therapeutic use Male Partial Thromboplastin Time Amyloidogenic Proteins Antineoplastic Agents Blood Coagulation Factors Immunosuppressive Agents Factor X
PMC6452584
30947547
Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis
2019